Cold Chain Technologies (CCT), has reinforced its commitment to expanding its Asia Pacific (APAC) presence with a series of investments and partnerships.
Bio-Rad Laboratories, a specialist in life science research and clinical diagnostics products, has announced the introduction of a new range of StarBright Dyes, designed to provide greater choice for spectral flow cytometry in immunology research.
Scenic Biotech, a pioneer in modifier therapies for severe diseases, has announced a license and research agreement with Alnylam Pharmaceuticals to leverage Scenic's Cell-Seq platform for discovering novel targets for RNAi therapeutics.
Er-Kim, an international pharma company specialising in the commercialisation of novel therapies, has announced a distribution agreement with CNX Therapeutics to supply selected oncology products across Central & Eastern Europe (CEE) and Türkiye.
ITF Therapeutics, the U.S. affiliate of Italfarmaco, has announced publication of positive long-term safety and efficacy data for givinostat as a treatment for Duchenne muscular dystrophy (DMD).
Auto-injectors and pens enable patients to self-administer medication safely. These modern application systems replace visits to the doctor and reduce the burden on the healthcare system.
KNAPP will present its range of solutions for the sector on its stand (F20) at The Pharmacy Show, which takes place on 12-13th October at the NEC in Birmingham.
Nemera relies on Mitutoyo measurement and inspection solutions to ensure its health-critical dispensers, inhalers and pens deliver the exact specified amount of active ingredient.
Michael Franco, director of Global Biopharma Sales, PSG Biotech explores the question: "how do we maintain the benefits of single-use while reducing the environmental burden they create?"
The Hosokawa Micron Group and its subsidiaries will be presenting their range of products and services in Hall 11, Stand 137 at Powtech Technopharm 2025 in Nuremberg from 23 - 25th September.
Asymchem, a company in contract development and manufacturing (CDMO) solutions, has announced an expansion of its flow chemistry capabilities at its Sandwich, UK facility.
